Advertisement Photo Therapeutics receives FDA approval for light therapy device - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Photo Therapeutics receives FDA approval for light therapy device

Photo Therapeutics has received the FDA approval for its new over-the-counter light therapy device, Omnilux New-U, for the treatment of periorbital wrinkles.

Omnilux New-U has been clinically proven to reduce periorbital wrinkles and to treat the visible signs of aging, using a combination of alternate treatments of infrared and red light twice a week for four weeks.

Sue D’Arcy, CEO of Photo Therapeutics, said: “We believe in producing light therapy devices that deliver optimized treatment parameters that have been rigorously tested and clinically proven, and our latest technological achievement is no different.”